New patent for the drug Astrazeneca LYNPARZA – DrugPatentWatch
Annual Drug Patent Expiration for LYNPARZA
Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from a single supplier. There are eleven patents protecting this drug.
Drug patent litigation for LYNPARZA.
This drug has two hundred and fifty-seven patent family members in fifty one countries.
The generic ingredient in LYNPARZA is mesmerizing. One registered supplier for this compound. Additional details are available on the olaparib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Astrazeneca LYNPARZA
